Cargando…

Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis

We report a case of a 41-year-old male who presented with tachycardia and swelling of his left arm six weeks after he started antituberculosis treatment and stopped his rheumatoid arthritis infliximab treatment. He was diagnosed with pulmonary embolism by chest CT and initially treated with warfarin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Brian, Moosavy, Farid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228825/
https://www.ncbi.nlm.nih.gov/pubmed/25530902
http://dx.doi.org/10.1155/2014/479025
_version_ 1782344048043884544
author Lee, Brian
Moosavy, Farid
author_facet Lee, Brian
Moosavy, Farid
author_sort Lee, Brian
collection PubMed
description We report a case of a 41-year-old male who presented with tachycardia and swelling of his left arm six weeks after he started antituberculosis treatment and stopped his rheumatoid arthritis infliximab treatment. He was diagnosed with pulmonary embolism by chest CT and initially treated with warfarin, which interacted with his antituberculosis treatment. This presentation of deep vein thrombosis and pulmonary embolism as part of immune reconstitution inflammatory syndrome has not been previously reported for infliximab treated patients.
format Online
Article
Text
id pubmed-4228825
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-42288252014-12-21 Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis Lee, Brian Moosavy, Farid Case Rep Pulmonol Case Report We report a case of a 41-year-old male who presented with tachycardia and swelling of his left arm six weeks after he started antituberculosis treatment and stopped his rheumatoid arthritis infliximab treatment. He was diagnosed with pulmonary embolism by chest CT and initially treated with warfarin, which interacted with his antituberculosis treatment. This presentation of deep vein thrombosis and pulmonary embolism as part of immune reconstitution inflammatory syndrome has not been previously reported for infliximab treated patients. Hindawi Publishing Corporation 2014 2014-10-29 /pmc/articles/PMC4228825/ /pubmed/25530902 http://dx.doi.org/10.1155/2014/479025 Text en Copyright © 2014 B. Lee and F. Moosavy. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Lee, Brian
Moosavy, Farid
Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis
title Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis
title_full Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis
title_fullStr Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis
title_full_unstemmed Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis
title_short Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis
title_sort pulmonary embolism following cessation of infliximab for treatment of miliary tuberculosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228825/
https://www.ncbi.nlm.nih.gov/pubmed/25530902
http://dx.doi.org/10.1155/2014/479025
work_keys_str_mv AT leebrian pulmonaryembolismfollowingcessationofinfliximabfortreatmentofmiliarytuberculosis
AT moosavyfarid pulmonaryembolismfollowingcessationofinfliximabfortreatmentofmiliarytuberculosis